SIMPLIRIX

GlaxoSmithKline Biologicals S.A.

Application Filed: 2003-03-07

Trademark Application Details

Status

710

Dead/Cancelled

CANCELLED - SECTION 8

Research	OneLook Acronym Finder
Serial Number	78223045
Registration Number	2877223
Mark Drawing Code	1000: Typeset: Word(s)/letter(s)/number(s)
Cancellation Code	2
Domestic Representative	Maribeth Day Case
Attorney Name	Maribeth Day Case
Law Office Assigned	L80
Employee Name	CHOINIERE, MONIQUE

Timeline

2003-03-07	Application Filed
2004-06-01	Published for Opposition
2004-08-24	Trademark Registered
2004-08-30	Location: FILE REPOSITORY (FRANCONIA)
2011-03-25	Cancelled
2011-03-25	Status: Dead/Cancelled
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	GlaxoSmithKline Biologicals S.A.
Address	Rue de l'Institut 89 Rixensart BE B-1330
Legal Entity Type	Corporation
Legal Entity State	BE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Maribeth Day Case (who was appointed att
GlaxoSmithKline
Five Moore Drive
LGTM, C.3157.3D
Research Triangle Park NC 27709

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	vaccine for human use to prevent herpes

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	2003-08-23	1 DOCK D:Assigned to Examiner
NON-FINAL ACTION E-MAILED	2003-08-25	2 GNRT F:First Action
NON-FINAL ACTION MAILED	2003-08-27	3 CNRT O:Outgoing Correspondence
TEAS RESPONSE TO OFFICE ACTION RECEIVED	2004-02-09	4 TROA I:Incoming Correspondence
CORRESPONDENCE RECEIVED IN LAW OFFICE	2004-02-09	5 CRFA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2004-03-16	6 CNSA O:Outgoing Correspondence
NOTICE OF PUBLICATION	2004-05-12	7 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	2004-06-01	8 PUBO A:Allowance for Publication
REGISTERED-PRINCIPAL REGISTER	2004-08-24	9 R.PR A:Allowance for Publication
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED	2009-12-03	10 REAP I:Incoming Correspondence
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED	2009-12-03	11 ARAA I:Incoming Correspondence
TEAS CHANGE OF CORRESPONDENCE RECEIVED	2010-05-13	12 TCCA I:Incoming Correspondence
CANCELLED SEC. 8 (6-YR)	2011-03-25	13 C8.. O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
SIMPLIRIX 78601706 3161763 Dead/Cancelled	GlaxoSmithKline Biologicals S.A. 2005-04-05
SIMPLIRIX 78223045 2877223 Dead/Cancelled	GlaxoSmithKline Biologicals S.A. 2003-03-07
SIMPLIRIX 76291391 2545040 Dead/Cancelled	SmithKline Beecham Biologicals, S.A. 2001-07-26
SIMPLIRIX 76290988 2545037 Dead/Cancelled	SmithKline Beecham Biologicals, S.A. 2001-07-26
SIMPLIRIX 76289032 not registered Dead/Abandoned	SmithKline Beecham Biologicals, S.A. 2001-07-20
SIMPLIRIX 75457530 2240730 Dead/Cancelled	SmithKline Beecham Biologicals S.A. 1998-03-26
SIMPLIRIX 75331006 not registered Dead/Abandoned	SmithKline Beecham Biologicals S.A. 1997-07-25
SIMPLIRIX 75330982 not registered Dead/Abandoned	SmithKline Beecham Biologicals S.A. 1997-07-25
SIMPLIRIX 75077526 not registered Dead/Abandoned	SmithKline Beecham Biologicals S.A. 1996-03-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.